Stocks and Investing Stocks and Investing
Thu, November 8, 2018
[ 12:00 AM ] - WOPRAI
Andrew Wittmann Maintained (TTEK) at Hold with Increased Target to $14 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Nicole Deblase Initiated (SWK) at Hold and Held Target at $136 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Stephen Biggar Maintained (SNY) at Strong Buy with Increased Target to $50 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Chris Howerton Initiated (VNDA) at Strong Buy and Held Target at $26 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Chris Parkinson Maintained (ASH) at Buy with Increased Target to $97 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Ross Seymore Initiated (AVGO) at Strong Buy and Held Target at $31 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Harlan Sur Initiated (AVGO) at Buy and Held Target at $33 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (WEN) at Hold and Held Target at $18 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Mark Mananey Maintained (CARG) at Buy with Increased Target to $59 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Gregory Miller Downgraded (CABO) to Hold on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Matthew Mishan Maintained (BDX) at Buy with Increased Target to $273 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Tavis McCourt Maintained (ALRM) at Strong Buy with Increased Target to $58 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Dave Kang Maintained (AAOI) at Hold with Decreased Target to $19 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Jonathan Lanterman Maintained (ZG) at Hold with Decreased Target to $33 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Jonathan Lanterman Maintained (Z) at Hold with Decreased Target to $33 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Increased Target to $63 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
Michael Yee Initiated (URGN) at Strong Buy and Held Target at $77 on, Nov 8th, 2018
[ 12:00 AM ] - WOPRAI
David Coleman Upgraded (ADM) to Strong Buy on, Nov 8th, 2018
Wed, November 7, 2018
[ 12:00 AM ] - WOPRAI
Daniel Ford Maintained (AES) at Hold with Decreased Target to $14 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
TJ Schultz Upgraded (USAC) to Buy and Held Target at $21 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Shyam Patil Downgraded (Z) to Sell and Held Target at $23 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Shyam Patil Downgraded (ZG) to Sell and Held Target at $23 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Kevin Barker Upgraded (ZION) to Buy and Increased Target to $57 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Dennis Coleman Upgraded (WES) to Strong Buy and Held Target at $51 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Tycho Peterson Downgraded (AXDX) to Hold and Decreased Target to $160 on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Raju Prasad Downgraded (BOLD) to Hold on, Nov 7th, 2018
[ 12:00 AM ] - WOPRAI
Oliver Chen Upgraded (TGT) to Buy and Held Target at $100 on, Nov 7th, 2018
Tue, November 6, 2018
[ 12:00 AM ] - WOPRAI
Peter Christiansen Upgraded (SQ) to Strong Buy and Held Target at $90 on, Nov 6th, 2018
[ 12:00 AM ] - WOPRAI
Jeffrey Silber Maintained (SRCL) at Hold with Decreased Target to $51 on, Nov 6th, 2018
[ 12:00 AM ] - WOPRAI
Joel Beatty Maintained (SRPT) at Strong Buy with Increased Target to $188 on, Nov 6th, 2018

Joel Beatty Maintained (SRPT) at Strong Buy with Increased Target to $188 on, Nov 6th, 2018


Published on 2024-10-26 10:28:51 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Citigroup, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $174 to $188 on, Nov 6th, 2018.

Joel has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Joel's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joel

  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $178 on, Thursday, September 6th, 2018
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Wednesday, August 1st, 2018
Contributing Sources